Eventide reports 4% stake in Xometry stock
Eventide Asset Management, LLC, together with Finny Kuruvilla, M.D., Ph.D. and Robin C. John, reports beneficial ownership of 2,151,845 shares of Xometry, Inc. Class A common stock, representing 4.0% of the class.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Eventide Asset Management, LLC, together with Finny Kuruvilla, M.D., Ph.D. and Robin C. John, reports beneficial ownership of 2,151,845 shares of Xometry, Inc. Class A common stock, representing 4.0% of the class. Eventide holds sole voting and dispositive power over these shares, while Kuruvilla and John are reported as having shared voting and dispositive power over the same 2,151,845 shares. The group states that it now owns 5 percent or less of the class and, pursuant to Rule 13d-4, each filer expressly disclaims beneficial ownership of the securities. A joint filing agreement under Rule 13d-1(k)(1) confirms that this Schedule 13G/A is filed on behalf of all three reporting persons.
Key Figures
Key Terms
beneficial ownership financial
sole voting power financial
Schedule 13G regulatory
Rule 13d-4 regulatory
Rule 13d-1(k)(1) regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What ownership stake in XMTR does Eventide report in this Schedule 13G/A?
Who are the reporting persons on this XMTR Schedule 13G/A amendment?
What does the beneficial ownership disclaimer mean in this XMTR filing?
What is the purpose of the joint filing agreement in this XMTR Schedule 13G/A?
AI-generated analysis. How Rhea-AI works. Not financial advice.